Veterinary Medicine Market Forecast to 2030
Market Report I 2023-07-13 I 138 Pages I Market Research Future
Veterinary Medicine Market Forecast to 2030
Market Overview
The veterinary medicine market is projected to register a healthy CAGR of 5.57% by 2030. Developing persistent diseases, expanding paces of pet proprietorship, and expanded meat and the extension of the veterinary medicine industry may be energized by endeavors to advance animal cultivation and an expansion in pet reception are the key market drivers improving the Veterinary Medicine market development.
The market improvement is anticipated to be supported by the rising reception of pet medical coverage to pay for veterinary administrations in different industrialized countries. Sweden, the Unified Realm, and Canada have flourishing pet healthcare coverage markets. There has been a sharp ascent in the boundless utilization of pet healthcare coverage in China. Two huge elements adding to the acknowledgment of pet medical care protection are the developing public comprehension of pet medical problems and the rising ubiquity of pets.
Market Segmentation
The market portions of Veterinary Medicine, considering the course of administration, incorporate oral and parental. The Veterinary Medicine market division, by Animal Type, incorporates Tamed and Sidekick animals.
Based on Product, the market portions of Veterinary Medicine incorporate Medications and Immunizations. In view of the Distribution Channel, the market of the veterinary medicine division incorporates Veterinary Medical clinics and Centers, Retail locations, and Online Drug stores.
Regional Analysis
The North American Veterinary Medicine market represented USD 12.48 billion in 2021 and is supposed to display a huge CAGR development during the review time frame.
The Asia Pacific Veterinary Medicine market is expected to increment considerably during the period. Market extension in this space has been helped by expanded friend creature reception and rising creature wellbeing concerns. The Asia Pacific region's market is likewise expected to be driven by rising veterinary and creature medical care costs and a sizable cow populace. Besides, the China market of veterinary medicine held the biggest market share, and the Indian market of veterinary medicine was the quickest developing market in the Asia-Pacific region.
Because of the inescapable presence of huge industry players and the Region's advanced medical care framework, Europe is expected to rule the market of veterinary medicine over the projection period. Moreover, strong unofficial laws and extending measures to advance creature well-being will additionally speed up this Region's market improvement rate.
Significant market organizations are putting critical cash in Research and development to extend their item contributions, which will fuel further market development in Veterinary Medicine. With huge industry changes, including new item deliveries, legally binding arrangements, consolidations, and acquisitions, expanded speculations, and cooperation with different associations, market members are likewise attempted different vital exercises to extend their presence.
Producing locally to reduce functional expenses is one of the primary business strategies utilized by the Veterinary Medicine industry to serve clients and increment the market area. The Veterinary Medicine industry has as of late given medicine the absolute most significant benefits.
Major Players
Key Companies in the Veterinary Medicine market are Ceva, Boehringer Ingelheim, Dechra Pharmaceuticals plc, Bayer AG, Chanelle Pharma Group, Elanco, Norbrook Laboratories, Merck Animal Health, Vetiqyubik S.A., and Zoetis.
TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 15
2.2 RESEARCH OBJECTIVE 15
2.3 MARKET STRUCTURE 15
2.4 ASSUMPTIONS & LIMITATIONS 16
3 RESEARCH METHODOLOGY
3.1 DATA MINING 17
3.2 SECONDARY RESEARCH 18
3.3 PRIMARY RESEARCH 19
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 20
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.6.1 BOTTOM-UP APPROACH 23
3.6.2 TOP-DOWN APPROACH 23
3.7 DATA TRIANGULATION 24
3.8 VALIDATION 24
4 MARKET DYNAMICS
4.1 OVERVIEW 25
4.2 DRIVERS 26
4.2.1 GROWING RATES OF PET OWNERSHIP 26
4.2.2 RISING ZOONOTIC & CHRONIC DISEASES ANIMALS 26
4.2.3 INCREASING MEAT CONSUMPTION ATTRACTING MANDATORY VACCINATION 26
4.3 RESTRAINT 27
4.3.1 SHORTAGE OF VETERINARIANS 27
4.3.2 STRINGENT REGULATORY GUIDELINES PERTAINING TO VACCINES APPROVAL FOR ANIMALS 27
4.4 OPPORTUNITY 28
4.4.1 INCREASING INVESTMENT IN VETERINARY HOSPITALS 28
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS 29
5.1.1 R&D 30
5.1.2 MANUFACTURING 30
5.1.3 DISTRIBUTION & SALES 30
5.1.4 POST-SALES REVIEW/MONITORING 30
5.2 PORTER'S FIVE FORCES MODEL 31
5.2.1 THREAT OF NEW ENTRANTS 31
5.2.2 BARGAINING POWER OF SUPPLIERS 32
5.2.3 THREAT OF SUBSTITUTES 32
5.2.4 BARGAINING POWER OF BUYERS 32
5.2.5 INTENSITY OF RIVALRY 32
5.3 IMPACT OF COVID-19 32
5.3.1 OVERVIEW 32
5.3.2 IMPACT ON MEAT CONSUMPTION 33
5.3.3 IMPACT ON VETERINARY MEDICINE MARKET 33
6 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE
6.1 OVERVIEW 34
6.2 DOMESTICATED 35
6.3 COMPANION 35
7 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT
7.1 OVERVIEW 37
7.2 DRUG 38
7.3 VACCINES 39
8 GLOBAL VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION
8.1 OVERVIEW 40
8.2 ORAL 41
8.3 PARENTERAL 41
8.4 OTHERS 42
9 GLOBAL VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW 43
9.2 VETERINARY HOSPITALS & CLINICS 44
9.3 RETAIL STORES 44
9.4 ONLINE PHARMACIES 45
10 GLOBAL VETERINARY MEDICINE MARKET, BY REGION
10.1 OVERVIEW 46
10.2 AMERICAS 48
10.2.1 NORTH AMERICA 50
10.2.1.1 US 52
10.2.1.2 CANADA 53
10.2.2 LATIN AMERICA 54
10.3 EUROPE 56
10.3.1 WESTERN EUROPE 58
10.3.1.1 GERMANY 60
10.3.1.2 UK 61
10.3.1.3 FRANCE 62
10.3.1.4 ITALY 63
10.3.1.5 SPAIN 64
10.3.1.6 REST OF WESTERN EUROPE 65
10.3.2 EASTERN EUROPE 67
10.4 ASIA-PACIFIC 69
10.4.1 CHINA 71
10.4.2 JAPAN 72
10.4.3 INDIA 73
10.4.4 AUSTRALIA 74
10.4.5 SOUTH KOREA 75
10.4.6 REST OF ASIA-PACIFIC 76
10.5 MIDDLE EAST & AFRICA 78
10.5.1 SAUDI ARABIA 80
10.5.2 UNITED ARAB EMIRATES 81
10.5.3 OMAN 83
10.5.4 KUWAIT 84
10.5.5 QATAR 85
10.5.6 REST OF THE MIDDLE EAST & AFRICA 86
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 88
11.2 COMPETITIVE BENCHMARKING 89
11.3 GLOBAL VETERINARY MEDICINE MARKET: COMPANY RANKING 90
11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 91
11.5 MAJOR GROWTH STRATEGY IN THE GLOBAL VETERINARY MEDICINE MARKET 91
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 92
11.6.1 NEW PRODUCT LAUNCHES 92
11.6.2 PARTNERSHIPS/AGREEMENTS 92
11.6.3 EXPANSIONS 93
11.6.4 ACQUISITIONS 93
11.7 FINANCIAL MATRIX 94
12 COMPANY PROFILES
12.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 96
12.1.1 COMPANY OVERVIEW 96
12.1.2 FINANCIAL OVERVIEW 97
12.1.3 PRODUCTS/SERVICES OFFERED 97
12.1.4 KEY DEVELOPMENTS 99
12.1.5 SWOT ANALYSIS 99
12.1.6 KEY STRATEGIES 100
12.2 CEVA 101
12.2.1 COMPANY OVERVIEW 101
12.2.2 FINANCIAL OVERVIEW 101
12.2.3 PRODUCTS/SERVICES OFFERED 102
12.2.4 KEY DEVELOPMENTS 102
12.2.5 SWOT ANALYSIS 103
12.2.6 KEY STRATEGIES 103
12.3 ZOETIS 104
12.3.1 COMPANY OVERVIEW 104
12.3.2 FINANCIAL OVERVIEW 104
12.3.3 PRODUCTS/SERVICES OFFERED 105
12.3.4 KEY DEVELOPMENTS 107
12.3.5 SWOT ANALYSIS 107
12.3.6 KEY STRATEGIES 107
12.4 MERCK ANIMAL HEALTH 108
12.4.1 COMPANY OVERVIEW 108
12.4.2 FINANCIAL OVERVIEW 109
12.4.3 PRODUCTS/SERVICES OFFERED 110
12.4.4 KEY DEVELOPMENTS 111
12.4.5 SWOT ANALYSIS 112
12.4.6 KEY STRATEGIES 112
12.5 CHANELLE PHARMA GROUP 113
12.5.1 COMPANY OVERVIEW 113
12.5.2 FINANCIAL OVERVIEW 113
12.5.3 PRODUCTS/SERVICES OFFERED 113
12.5.4 KEY DEVELOPMENTS 115
12.5.5 SWOT ANALYSIS 115
12.5.6 KEY STRATEGIES 115
12.6 ELANCO 116
12.6.1 COMPANY OVERVIEW 116
12.6.2 FINANCIAL OVERVIEW 117
12.6.3 PRODUCTS/SERVICES OFFERED 118
12.6.4 KEY DEVELOPMENTS 119
12.6.5 SWOT ANALYSIS 120
12.6.6 KEY STRATEGIES 120
12.7 DECHRA PHARMACEUTICALS PLC 121
12.7.1 COMPANY OVERVIEW 121
12.7.2 FINANCIAL OVERVIEW 121
12.7.3 PRODUCTS/SERVICES OFFERED 122
12.7.4 KEY DEVELOPMENTS 123
12.7.5 SWOT ANALYSIS 123
12.7.6 KEY STRATEGIES 123
12.8 BAYER AG 124
12.8.1 COMPANY OVERVIEW 124
12.8.2 FINANCIAL OVERVIEW 124
12.8.3 PRODUCTS/SERVICES OFFERED 125
12.8.4 KEY DEVELOPMENTS 126
12.8.5 SWOT ANALYSIS 127
12.8.6 KEY STRATEGIES 127
12.9 VETOQUINOL SA. 128
12.9.1 COMPANY OVERVIEW 128
12.9.2 FINANCIAL OVERVIEW 128
12.9.3 PRODUCTS/SERVICES OFFERED 129
12.9.4 KEY DEVELOPMENTS 131
12.9.5 SWOT ANALYSIS 132
12.9.6 KEY STRATEGIES 132
12.10 NORBROOK LABORATORIES 133
12.10.1 COMPANY OVERVIEW 133
12.10.2 FINANCIAL OVERVIEW 133
12.10.3 PRODUCTS/SERVICES OFFERED 133
12.10.4 KEY DEVELOPMENTS 135
12.10.5 SWOT ANALYSIS 135
12.10.6 KEY STRATEGIES 136
13 APPENDIX
13.1 REFERENCES 137
13.2 RELATED REPORTS 138
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 16
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19
TABLE 3 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 34
TABLE 4 GLOBAL VETERINARY MEDICINE MARKET FOR DOMESTICATED, BY REGION,2018-2030 (USD MILLION) 35
TABLE 5 GLOBAL VETERINARY MEDICINE MARKET FOR COMPANION, BY REGION,2018-2030 (USD MILLION) 36
TABLE 6 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 37
TABLE 7 GLOBAL VETERINARY MEDICINE MARKET FOR DRUG, BY REGION,2018-2030 (USD MILLION) 38
TABLE 8 GLOBAL VETERINARY MEDICINE MARKET FOR VACCINES, BY REGION,2018-2030 (USD MILLION) 39
TABLE 9 GLOBAL VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 40
TABLE 10 GLOBAL VETERINARY MEDICINE MARKET FOR ORAL, BY REGION,2018-2030 (USD MILLION) 41
TABLE 11 GLOBAL VETERINARY MEDICINE MARKET FOR PARENTERAL, BY REGION,2018-2030 (USD MILLION) 41
TABLE 12 GLOBAL VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 43
TABLE 13 GLOBAL VETERINARY MEDICINE MARKET FOR VETERINARY HOSPITALS & CLINICS, BY REGION,2018-2030 (USD MILLION) 44
TABLE 14 GLOBAL VETERINARY MEDICINE MARKET FOR RETAIL STORES, BY REGION,2018-2030 (USD MILLION) 45
TABLE 15 GLOBAL VETERINARY MEDICINE MARKET FOR ONLINE PHARMACIES, BY REGION,2018-2030 (USD MILLION) 45
TABLE 16 GLOBAL VETERINARY MEDICINE MARKET, BY REGION,2018-2030 (USD MILLION) 46
TABLE 17 AMERICAS: VETERINARY MEDICINE MARKET, BY REGION,2018-2030 (USD MILLION) 48
TABLE 18 AMERICAS: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 49
TABLE 19 AMERICAS: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 49
TABLE 20 AMERICAS: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 49
TABLE 21 AMERICAS: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 49
TABLE 22 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY COUNTRY,2018-2030 (USD MILLION) 50
TABLE 23 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 50
TABLE 24 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 51
TABLE 25 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 51
TABLE 26 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 51
TABLE 27 US: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 52
TABLE 28 US: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 52
TABLE 29 US: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 52
TABLE 30 US: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 52
TABLE 31 CANADA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 53
TABLE 32 CANADA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 53
TABLE 33 CANADA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 53
TABLE 34 CANADA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 53
TABLE 35 LATIN AMERICA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 54
TABLE 36 LATIN AMERICA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 54
TABLE 37 LATIN AMERICA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 54
TABLE 38 LATIN AMERICA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 55
TABLE 39 EUROPE: VETERINARY MEDICINE MARKET, BY REGION,2018-2030 (USD MILLION) 56
TABLE 40 EUROPE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 57
TABLE 41 EUROPE: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 57
TABLE 42 EUROPE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 57
TABLE 43 EUROPE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 57
TABLE 44 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY COUNTRY,2018-2030 (USD MILLION) 58
TABLE 45 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 58
TABLE 46 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 59
TABLE 47 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 59
TABLE 48 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 59
TABLE 49 GERMANY: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 60
TABLE 50 GERMANY: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 60
TABLE 51 GERMANY: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 60
TABLE 52 GERMANY: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 61
TABLE 53 UK: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 61
TABLE 54 UK: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 61
TABLE 55 UK: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 61
TABLE 56 UK: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 62
TABLE 57 FRANCE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 62
TABLE 58 FRANCE: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 62
TABLE 59 FRANCE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 62
TABLE 60 FRANCE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 63
TABLE 61 ITALY: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 63
TABLE 62 ITALY: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 63
TABLE 63 ITALY: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 63
TABLE 64 ITALY: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 64
TABLE 65 SPAIN: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 64
TABLE 66 SPAIN: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 64
TABLE 67 SPAIN: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 65
TABLE 68 SPAIN: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 65
TABLE 69 REST OF WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 65
TABLE 70 REST OF WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 66
TABLE 71 REST OF WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 66
TABLE 72 REST OF WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 66
TABLE 73 EASTERN EUROPE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 67
TABLE 74 EASTERN EUROPE: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 67
TABLE 75 EASTERN EUROPE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 67
TABLE 76 EASTERN EUROPE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 68
TABLE 77 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY COUNTRY,2018-2030 (USD MILLION) 69
TABLE 78 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 70
TABLE 79 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 70
TABLE 80 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 70
TABLE 81 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 70
TABLE 82 CHINA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 71
TABLE 83 CHINA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 71
TABLE 84 CHINA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 71
TABLE 85 CHINA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 71
TABLE 86 JAPAN: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 72
TABLE 87 JAPAN: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 72
TABLE 88 JAPAN: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 72
TABLE 89 JAPAN: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 72
TABLE 90 INDIA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 73
TABLE 91 INDIA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 73
TABLE 92 INDIA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 73
TABLE 93 INDIA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 73
TABLE 94 AUSTRALIA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 74
TABLE 95 AUSTRALIA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 74
TABLE 96 AUSTRALIA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 74
TABLE 97 AUSTRALIA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 75
TABLE 98 SOUTH KOREA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 75
TABLE 99 SOUTH KOREA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 75
TABLE 100 SOUTH KOREA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 76
TABLE 101 SOUTH KOREA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 76
TABLE 102 REST OF ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 76
TABLE 103 REST OF ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 77
TABLE 104 REST OF ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 77
TABLE 105 REST OF ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 77
TABLE 106 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY COUNTRY/REGION,2018-2030 (USD MILLION) 78
TABLE 107 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 79
TABLE 108 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 79
TABLE 109 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 79
TABLE 110 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 80
TABLE 111 SAUDI ARABIA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 80
TABLE 112 SAUDI ARABIA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 80
TABLE 113 SAUDI ARABIA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 81
TABLE 114 SAUDI ARABIA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 81
TABLE 115 UAE VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 81
TABLE 116 UAE VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 82
TABLE 117 UAE VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 82
TABLE 118 UAE VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 82
TABLE 119 OMAN: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 83
TABLE 120 OMAN: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 83
TABLE 121 OMAN: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 83
TABLE 122 OMAN: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 83
TABLE 123 KUWAIT: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 84
TABLE 124 KUWAIT: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 84
TABLE 125 KUWAIT: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 84
TABLE 126 KUWAIT: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 84
TABLE 127 QATAR: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 85
TABLE 128 QATAR: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 85
TABLE 129 QATAR: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 85
TABLE 130 QATAR: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 85
TABLE 131 REST OF THE MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018-2030 (USD MILLION) 86
TABLE 132 REST OF THE MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY PRODUCT,2018-2030 (USD MILLION) 86
TABLE 133 REST OF THE MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018-2030 (USD MILLION) 86
TABLE 134 REST OF THE MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018-2030 (USD MILLION) 87
TABLE 135 MAJOR MANUFACTURERS RANKING, 2020 90
TABLE 136 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE VETERINARY MEDICINE MARKET 91
TABLE 137 NEW PRODUCT LAUNCHES 92
TABLE 138 PARTNERSHIPS/AGREEMENTS 92
TABLE 139 EXPANSIONS 93
TABLE 140 ACQUISITIONS 93
TABLE 141 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS/SERVICES OFFERED 97
TABLE 142 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS 99
TABLE 143 CEVA: PRODUCTS/SERVICES OFFERED 102
TABLE 144 CEVA: KEY DEVELOPMENTS 102
TABLE 145 ZOETIS: PRODUCTS/SERVICES OFFERED 105
TABLE 146 ZOETIS: KEY DEVELOPMENTS 107
TABLE 147 MERCK ANIMAL HEALTH: PRODUCTS/SERVICES OFFERED 110
TABLE 148 MERCK ANIMAL HEALTH: KEY DEVELOPMENTS 111
TABLE 149 CHANELLE PHARMA GROUP: PRODUCTS/SERVICES OFFERED 113
TABLE 150 CHANELLE PHARMA GROUP: KEY DEVELOPMENTS 115
TABLE 151 CHANELLE PHARMA GROUP: SWOT ANALYSIS 115
TABLE 152 ELANCO: PRODUCTS/SERVICES OFFERED 118
TABLE 153 ELANCO: KEY DEVELOPMENTS 119
TABLE 154 DECHRA PHARMACEUTICALS PLC: PRODUCTS/SERVICES OFFERED 122
TABLE 155 DECHRA PHARMACEUTICALS PLC: KEY DEVELOPMENTS 123
TABLE 156 BAYER AG: PRODUCTS/SERVICES OFFERED 125
TABLE 157 VETOQUINOL SA: PRODUCTS/SERVICES OFFERED 129
TABLE 158 VETOQUINOL SA: KEY DEVELOPMENTS 131
TABLE 159 NORBROOK LABORATORIES: PRODUCTS/SERVICES OFFERED 133
TABLE 160 NORBROOK LABORATORIES: KEY DEVELOPMENTS 135
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 14
FIGURE 2 GLOBAL VETERINARY MEDICINE MARKET 15
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 22
FIGURE 4 MARKET DYNAMICS: GLOBAL VETERINARY MEDICINE MARKET 25
FIGURE 5 DRIVERS: IMPACT ANALYSIS 27
FIGURE 6 RESTRAINT: IMPACT ANALYSIS 28
FIGURE 7 VALUE CHAIN ANALYSIS: VETERINARY MEDICINE MARKET 29
FIGURE 8 PORTER'S FIVE FORCES MODEL 31
FIGURE 9 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE,2018 & 2030 (USD MILLION) 34
FIGURE 10 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT,2018 & 2030 (USD MILLION) 37
FIGURE 11 GLOBAL VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION,2018 & 2030 (USD MILLION) 40
FIGURE 12 GLOBAL VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL,2018 & 2030 (USD MILLION) 43
FIGURE 13 GLOBAL VETERINARY MEDICINE MARKET, BY REGION,2018 & 2030 (USD MILLION) 46
FIGURE 14 GLOBAL VETERINARY MEDICINE MARKET SHARE, BY REGION, 2020 (%) 47
FIGURE 15 AMERICAS: VETERINARY MEDICINE MARKET SHARE, BY REGION, 2020 (%) 48
FIGURE 16 NORTH AMERICA: VETERINARY MEDICINE MARKET SHARE, BY COUNTRY, 2020 (%) 50
FIGURE 17 EUROPE: VETERINARY MEDICINE MARKET SHARE, BY REGION 2020 (%) 56
FIGURE 18 WESTERN EUROPE: VETERINARY MEDICINE MARKET SHARE, BY COUNTRY, 2020 (%) 58
FIGURE 19 ASIA-PACIFIC: VETERINARY MEDICINE MARKET SHARE, BY COUNTRY, 2020 (%) 69
FIGURE 20 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET SHARE, BY COUNTRY/REGION, 2020 (%) 78
FIGURE 21 BENCHMARKING OF MAJOR COMPETITORS 89
FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL VETERINARY MEDICINE MARKET 91
FIGURE 23 SALES & OPERATING INCOME, 2020 94
FIGURE 24 R&D EXPENDITURE, 2020 95
FIGURE 25 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT 97
FIGURE 26 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SWOT ANALYSIS 99
FIGURE 27 CEVA: FINANCIAL OVERVIEW SNAPSHOT 101
FIGURE 28 CEVA: SWOT ANALYSIS 103
FIGURE 29 ZOETIS: FINANCIAL OVERVIEW SNAPSHOT 104
FIGURE 30 ZOETIS: SWOT ANALYSIS 107
FIGURE 31 MERCK ANIMAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT 109
FIGURE 32 MERCK ANIMAL HEALTH: SWOT ANALYSIS 112
FIGURE 33 ELANCO: FINANCIAL OVERVIEW SNAPSHOT 117
FIGURE 34 ELANCO: SWOT ANALYSIS 120
FIGURE 35 DECHRA PHARMACEUTICALS PLC: FINANCIAL OVERVIEW SNAPSHOT 121
FIGURE 36 DECHRA PHARMACEUTICALS PLC: SWOT ANALYSIS 123
FIGURE 37 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT 124
FIGURE 38 BAYER AG: SWOT ANALYSIS 127
FIGURE 39 VETOQUINOL SA: FINANCIAL OVERVIEW SNAPSHOT 128
FIGURE 40 VETOQUINOL SA: SWOT ANALYSIS 132
FIGURE 41 NORBROOK LABORATORIES: SWOT ANALYSIS 135
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.